Cubist Systematic Strategies, LLC Kala Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $37,788 - $89,258	-32,576 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $30,373 - $62,949	-11,593 Reduced 26.25%	32,576 $85,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $415,350 - $668,992	-82,085 Reduced 65.02%	44,169 $234,000
Q1 2021 May 17, 2021	SELL	$6.24 - $9.58 $184,167 - $282,744	-29,514 Reduced 18.95%	126,254 $851,000
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $978,223 - $1.37 Million	155,768 New	155,768 $1.06 Million

Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $22,057 - $32,674	-2,941 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $24,498 - $40,556	2,941 New	2,941 $31,000
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $57,282 - $99,001	-11,037 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $47,348 - $109,707	11,037 New	11,037 $54,000
Q4 2017 Feb 14, 2018	SELL	$13.68 - $23.17 $136,499 - $231,190	-9,978 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $198,163 - $264,716	9,978	9,978 $228,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.